[Usefulness of supplemental treatment with glypressin during the eradication phase of esophageal varices using endoscopic sclerotherapy].
The response of 20 patients with oesophageal varices randomly assigned to treatment by endoscopic sclerotherapy with or without adjuvant Glipressina was assessed on the basis of the following parameters: mean eradication time for oesophageal varices and frequency of bleeding during that period. The preliminary results suggest that the drug may have a favourable influence on both eradication time and bleeding in sclerotherapy.
Palazzi
A
A
Laurenzi
F
F
Tiburzi
C
C
Ottaviani
O
O
D000328:Adult; D004724:Endoscopy; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D006801:Humans; D008236:Lypressin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D000077585:Terlipressin; D013997:Time Factors
D012597:Sclerosing Solutions; D008236:Lypressin; D000077585:Terlipressin
Utilità del trattamento complementare con Glipressina durante la fase di eradicazione delle varici esofagee mediante scleroterapia per via endoscopica.